Altered Islet Composition and Disproportionate Loss of Large Islets in Patients with Type 2 Diabetes by Kilimnik, German et al.
Altered Islet Composition and Disproportionate Loss of










1Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America, 2Laboratory of Biological Modeling, National Institute of Diabetes and
Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America, 3Department of Surgery, The University of Chicago, Chicago,
Illinois, United States of America
Abstract
Human islets exhibit distinct islet architecture with intermingled alpha- and beta-cells particularly in large islets. In this
study, we quantitatively examined pathological changes of the pancreas in patients with type 2 diabetes (T2D). Specifically,
we tested a hypothesis that changes in endocrine cell mass and composition are islet-size dependent. A large-scale analysis
of cadaveric pancreatic sections from T2D patients (n=12) and non-diabetic subjects (n=14) was carried out combined with
semi-automated analysis to quantify changes in islet architecture. The method provided the representative islet distribution
in the whole pancreas section that allowed us to examine details of endocrine cell composition in individual islets. We
observed a preferential loss of large islets (.60 mm in diameter) in T2D patients compared to non-diabetic subjects. Analysis
of islet cell composition revealed that the beta-cell fraction in large islets was decreased in T2D patients. This change was
accompanied by a reciprocal increase in alpha-cell fraction, however total alpha-cell area was decreased along with beta-
cells in T2D. Delta-cell fraction and area remained unchanged. The computer-assisted quantification of morphological
changes in islet structure minimizes sampling bias. Significant beta-cell loss was observed in large islets in T2D, in which
alpha-cell ratio reciprocally increased. However, there was no alpha-cell expansion and the total alpha-cell area was also
decreased. Changes in islet architecture were marked in large islets. Our method is widely applicable to various specimens
using standard immunohistochemical analysis that may be particularly useful to study large animals including humans
where large organ size precludes manual quantitation of organ morphology.
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Introduction
Type 2 diabetes (T2D) is a metabolic disease caused by a
relative lack of insulin- mediated control of glucose homeostasis.
The gradual progression of T2D hampers determination of the
precise onset of the disease. The diagnosis is currently only
confirmed when a patient develops chronic hyperglycemia, which
is recognized by the patient with various symptoms such as
excessive thirst, frequent urination, fatigue, blurred vision, and
weight loss. As the onset of T2D is poorly defined, this silent aspect
of disease progression has been noted as one of the major obstacles
for the treatment of T2D. Levetan et al. have reported that 40% of
hospitalized patients with T2D were undiagnosed [1]. It has been
estimated that most patients with T2D are not diagnosed until
,10 years after the disease onset [2].
The unclear pathogenesis leads to incomplete understanding
of the disease. While it is well-known that type 1 diabetes results
from selective autoimmune destruction of pancreatic beta-cells,
there is still considerable debate over the degree of beta-cell loss
in T2D in relation to beta-cell dysfunction [3–5], which has
important clinical implications regarding the treatment of the
disease including possible regenerative therapies. The challenge of
developing in vivo imaging modalities of beta-cell mass in humans is
well recognized, and pancreas biopsy is not an option. Therefore,
we reasoned that it is critical to obtain maximal information from
available autopsy specimens. In fact, it is only recently that
cadaveric pancreas specimens have been made more accessible to
the scientific community, owing in part to the clinical success of
islet transplantation, in which the assessment of the donor
pancreas and islet quality is an important issue to improve the
clinical outcomes.
Recent immunohistochemistry studies of the human pancreas
have demonstrated the distinct islet architecture with more alpha-
cells intermingled with beta-cells in humans compared to rodents
with the central core of beta-cells with less alpha-cells residing in
the periphery [6–8]. In interspecies comparative studies, we have
shown that such drastic morphological changes occur selectively in
large islets (.50–100 mm in diameter) in humans, and similar
changes are also observed in mice under conditions of an increased
demand for insulin such as pregnancy, obesity and diabetes [9,10].
In large animals, including humans, a proportionate increase in
the pancreas size, islet number and total islet mass compensates for
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27445an increased demand for insulin [11,12]. However, there is no
increase in the range of islet sizes in humans compared to that in
mice as well as in various other species, where the maximum
diameter is around 500 mm [9,10] suggesting that there are certain
regulatory mechanisms that maintain optimal islet sizes in order to
ensure their functional properties. The striking plasticity of islet
architecture in large islets together with changes in islet size
distribution may be used as additional parameters to assess the
pathological changes in the pancreas. Collectively, morphological
and pathological studies of autopsy pancreatic tissues provide
valuable information that may not have been fully explored.
Here we propose to develop a comprehensive evaluation
method of autopsy studies in order to better understand the
pathophysiology of T2D within the limited sample size and tissues
from each specimen. The large-scale analysis quantifies morphol-
ogy and cellular composition of individual islets. We found a
preferential loss of large islets (diameter .60 mm) accompanied by
total beta- and alpha-cell area, reduction of beta-cell fraction,
increase of alpha-cell fraction, and no change of delta-cell fraction
in the large islets. Furthermore, the present study reports the
unexpected complexity of pathophysiology of the pancreas, where
T2D (from clinical diagnosis and history of patients) does not
correlate simply with the degree of deterioration of the pancreas
by histology, but may involve a number of factors such as aging,
metabolic conditions, and intra-pancreatic fat accumulation.
Large-scale data collection combined with automated quantifica-
tion provides an unbiased baseline to further integrate various
environmental signals that affect pathophysiology of the pancreas
under metabolic disease states including T2D.
Materials and Methods
Human pancreas specimens
The autopsy specimens were collected at the University of
Chicago (D1, D2, D6, D7, D9, D12, ND1, ND2, ND4-ND9) and
Peninsula Medical School, Plymouth, UK and Royal Infirmary,
Glasgow, UK (D3-D5, D8, D10, D11, ND3, ND10-ND14). The
use of human tissues in the present study has been approved by the
Research Ethics Committee at Peninsula Medical School and
Glasgow Royal Infirmary, and the Institutional Review Board at
the University of Chicago. The need for consent was waived.
Immunohistochemistry
Paraffin-embedded sections with 6 mm in thickness were stained
with a polyclonal guinea pig anti-porcine insulin primary antibody
(DAKO, Carpinteria, CA), a mouse monoclonal anti-human
primary glucagon antibody (Sigma-Aldrich, St. Louis, MO), a
polyclonal goat anti-somatostatin (Santa Cruz, Santa Cruz, CA)
and DAPI (Invitrogen, Carlsbad, CA). The primary antibodies
were detected using a combination of DyLight 488, 549, and 649-
conjugated secondary antibodies (Jackson ImmunoResearch Lab.,
West Grove, PA).
Image capture and quantification
Microscopic images were taken with an Olympus IX8 DSU
spinning disk confocal microscope (Melville, NY) with imaging
software StereoInvestigator (SI, MicroBrightField, Williston, VT).
A modified method of ‘‘virtual slice capture’’ [13–15] was used.
Briefly, the SI controls a XYZ-motorized stage and acquires con-
secutive images and creates a high-resolution montage com-
posed of images obtained from multiple microscopic fields of view.
The entire tissue section was captured as ‘‘a virtual slice’’ using a
10x objective. Each virtual slice taken at four fluorescent channels
were further merged into one composite. Quantification of cellular
composition (i.e. each area of beta-, alpha-, and delta-cell
populations, and islet area by automated contouring of each islet)
was carried out using a macro written for ImageJ (http://rsbweb.
nih.gov/ij/). To measure coordinates of each islet-cell type, the
DAPI fluorescent signals were converted to 8-bit masks and
watershed to obtain masks of individual nuclei. The pixels
surrounding nuclei masks were quantified with respect to each
endocrine hormone staining (i.e. insulin, glucagon, or somatostat-
in) to identify which hormone was most prevalent around each
nucleus and to record islet-cell coordinates. DAPI signals outside
of islets were not included. Mathematica (Wolfram Research,
Champaign, IL) was used for mathematical analyses.
Characterization of islet architecture
The image analysis identifies individual islets on pancreatic
sections, and obtains center coordinates of every endocrine cell in
each islet. This allows us to calculate probabilities of contact
between cell types. For example, the probability, Paa, quantifies
how many alpha cells contact with alpha cells in an islet. To
identify a contact of two cells (i.e. neighborhood cells), we
calculated a distance between center coordinates of the two cells. If
the distance is less than a given threshold distance, they are defined





Table 1. Sample information.
ID Age Sex COD*/Clinical Information
D1 38 F Stroke.
D2 42 M Stroke.
D3 65 F Diabetic nephropathy.
D4 66 F Renal abscess.
D5 67 F Gastric cancer.
D6 67 F Intracranial bleeding. 7.5% HbA1c.
D7 71 F Head trauma. T2D for 15 years, on Insulin for 3 years,
high cholesterol, high BP. No alcohol, no cigarettes.
D8 71 M Diabetic for 5yr; leg gangrene.
D9 72 F Treated T2D for 15 years; HbA1c: 6.7%.
D10 73 M Meningitis.
D11 75 F Enteritis.
D12 81 M Anoxia. HbA1c: 5.5%.
ND1 15 M Anoxia.
ND2 21 M Head trauma.
ND3 24 M Trauma.
ND4 41 F Stroke
ND5 45 F Stroke.
ND6 47 M Stroke. Cigarette use, alcohol use, IV drug user; heroin
daily for 10 years, cocaine weekly for 5 years.
ND7 51 F Anoxia.
ND8 51 M Kidney stones. Stroke.
ND9 53 M Stroke.
ND10 63 F Pulmonary thromboembolism.
ND11 63 F Esophageal cancer.
ND12 68 M Ruptured esophagus.
ND13 73 M Stomach cancer.
ND14 81 M Colon cancer.
*COD: cause of death.
doi:10.1371/journal.pone.0027445.t001
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|cell diameter, which is the distance to the
second nearest-neighboring site in square lattice. We checked that
the small differences of the two threshold distances did not change
the probabilities of contact between cell types. Here it is not trivial
to determine ‘cell diameter’ from the only given information of
center coordinates of cells within an islet. We calculated distances
between every pair of nearest-neighboring cells on each islet. We
assume that the mean nearest-neighboring distance (20 6 12 mm)
corresponds to cell diameter because the center-to-center distance
between (perfectly) contacting cells is equal to cell diameter. If the
neighborhood of every cell in an islet is identified as described, it is
straightforward to calculate numbers of alpha-alpha, alpha-beta,
alpha-delta, beta-beta, beta-delta, and delta-delta contacts within
the islet. Then, the probabilities of contact between specific cell
types are just the contact number between them normalized by
total number of contact between cells. These quantities represent
islet architecture. For example, suppose we have a certain number
of alpha and beta cells. If contacts between homotypic cells were
preferable, we would observe more frequent alpha-alpha and beta-
beta contacts compared with random cell arrangement. Here
the probabilities of contact between cell types for the random cell
arrangement (Paa, Pbb, Pab) are theoretically estimated as
(Pa6Pa, Pb6Pb, Pa6Pb +Pb6Pa), for a given cellular composi-
tions (Pa, Pb).
Figure 1. Large-scale capture and computer-assisted semi-automated analysis of the whole tissue section. A: Virtual slice view of a
human pancreatic section (ND11) immunostained for insulin (green), glucagon (red), somatostatin (white) and nuclei (blue). A series of contiguous
images of a specimen is collected (illustrated as boxed panels) and merged into a single image montage (i.e. virtual slice; arrowed). A composite is
made by merging four overlapping virtual slice images. B: Views of each channel showing cellular composition. a. beta-cells, b. alpha-cells, c. delta-
cells, and d. composite of all three endocrine cells. Note that there is no overlap among the endocrine cell fractions. Corresponding converted 8-bit
masks after automatic thresholidng are shown in e. A contour shown in e (a red line) is used to measure islet area, which includes non-labeled area
(e.g. capillaries). Based on the captured center coordinates of each cell type within the given islet, its architecture is reconstructed in f.
doi:10.1371/journal.pone.0027445.g001
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Data are expressed as mean 6 SEM. Statistical analyses were
performed using Student’s t test. Differences were considered to be
significant at P, 0.05.
Results
Large-scale capture and computer-assisted
semi-automated analysis of the whole tissue section
Islet size distribution and cellular composition within whole
human pancreatic tissue sections from subjects with T2D were
examined using large-scale analyses that we have developed.
Specimens from those without a history of diabetes were also
included for comparison. The detailed information on the donors
(T2D, n=12 and non-diabetic, n=14) is summarized in Table 1.
The cases are listed by ascending age in each group. The method
to capture the entire distribution of islets within the whole section
and computer-assisted semi-automated data analyses are schemat-
ically described in Fig. 1. We have applied a method to quantify
the distribution of islets in the intact mouse pancreas, which has
been described in [13,14], and also shown in a visual article [15].
The modification of our method used in this study is to quantify
the islet size distribution along with information on beta-, alpha-,
and delta-cell composition within each islet as well as nuclei
(DAPI) by capturing fluorescence on four channels over the entire
section. Figure 1A shows a combined projection of all the channels
of immunohistochemical staining of a human pancreas section.
Note that the image including DAPI nuclei staining shows the
entire pancreas section. The computer-based automated method
identifies every islet with a specific identification number and
provides the precise quantification of cellular composition (i.e. the
area of beta-, alpha-, and delta-cells within a given islet; Fig. 1B).
Morphology of the pancreas and islets
Representative pancreas images shown in Fig. 2 are from
roughly selected specimens grouped by available clinical informa-
tion: (1) relatively young and healthy subjects (Fig. 2A: ND1, ND3,
ND4); (2) non-diabetic elderly subjects (Fig. 2B: ND11, ND13,
ND15); and (3) subjects with T2D (Fig. 2C: D2, D9, D11). Note
that partial regions of each whole section are shown in the same
scale for comparison with reasonable resolutions, due to the large
size (from 2 to 5 GB) of the original images. While, at a glance,
there appears to be an overall difference in total islet mass among
the three groups, the detailed analysis described below demon-
strates the complexity of beta-cell loss and clinical manifestations.
Several large and small islets randomly selected from each
section are presented in Fig. 3 (non-diabetic: ND4, ND7, ND10,
ND12 and T2D: D4, D8-D10; listed in ascending order of age in
each group). Islet architecture is well retained in small islets in all
specimens, whereas large islets exhibit various changes from
compacted endocrine cell arrangement (ND4, ND7, ND10,
ND12) to relatively sparse architecture (D4, D10), then to that
Figure 2. Representative pancreas images. A: Pancreatic sections immunostained for insulin (green), glucagon (red), somatostatin (white) and
nuclei (blue) of relatively young and healthy subjects. ND1: 15-yr, ND3: 24-yr, and ND4: 41-yr. B: Non-diabetic and aged subjects. ND11: 63-yr, ND13:
73-yr, and ND15: 81-yr. C: Subjects with T2D. D2: 42-yr, D9: 72-yr, and D11: 75-yr.
doi:10.1371/journal.pone.0027445.g002
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extreme example, a few large islets in the D8 pancreas contained a
cyst with necrotic materials that was not stained with DAPI.
Loss of beta- and alpha-cells and altered morphology in
large islets in T2D
Total islet cell composition (beta-cells in green, alpha-cells in red
and delta-cells in blue) in each specimen is compared between
non-diabetic (Fig. 4A.a) and T2D (Fig. 4A.b) subjects. Total islet
area was significantly decreased in T2D compared to non-diabetic
subjects (0.5 6 0.08% and 1.08 6 0.18%, respectively, P,0.008).
This decrease was due to total beta-cell loss (0.29 6 0.04% and
0.65 6 0.11%, respectively. P,0.006) as well as total alpha-cell
loss (0.16 6 0.04% and 0.35 6 0.06%, respectively, P,0.02).
There was a decrease in total delta-cell area, but the difference was
not statistically significant (0.04 6 0.01% and 0.09 6 0.03%,
respectively, P=0.13). Comparison of the ratio of large islets
(.100 mm in diameter, i.e. the clinically relevant size of islets) to
the total number of islets showed significant differences between
non-diabetic and T2D subjects (11.08 6 0.02% and 5.22 6
0.01%, respectively, P,0.007), confirming a preferential loss of
large islets by a simple comparison of the mean values of individual
subjects of the two groups (Fig. 4B). Accompanied with significant
changes in cellular composition in large islets, the presence of a few
large islets with altered islet morphology (Fig. 3) may provide
landmarks for the progression of overt diabetes (Fig. 4C). While
large human islets generally show the compacted endocrine cell
arrangement displaying alpha- and delta-cells being intermingled
with beta-cells (Fig. 4C.a: beta-cells shown in green, alpha-cell in
red and delta-cells in white), specimens from subjects with T2D
showed altered islet morphology: relatively sparse architecture
(Fig. 4C.b); the presence of a population of cells lacking cytosolic
hormones (blue; Fig. 4C.c); and cyst formation containing necrotic
materials (purple; Fig. 4C.d). No marked morphological changes
were observed in small islets (Fig. 4C. e-f).
Islet size distribution and cellular compositions
We further analyzed morphology of individual islets, and
examined their size distributions and cellular compositions,
depending on islet size, in non-diabetic (Fig. 5A) and T2D
(Fig. 5B) subjects. The results showed a large variation between
individuals. However, we were able to see significant differences of
islet morphology between the two groups. First, the relative
frequencies of large islets (.60 mm in diameter) were decreased in
T2D patients (Fig. 6A), confirming the preferential loss of large
islets in T2D (see Fig. 4B). In particular, larger islets (.160 mm)
showed more significant decrease. Note that while islets ranging
from 50 to 250 mm constitute only 10% of total number of islets,
they consist of 80% of the total islet area. Therefore, the significant
reduction in the area ratio of islets to pancreas in T2D resulted
from the preferential loss of the large islets. The most severe cases,
D4 and D6, showed overtly reduced islet area ratios, 0.22% and
0.19%, respectively, compared with the islet area ratio of non-
diabetic subjects examined (1.08 6 0.18%). It is noted that D9 had
a larger islet area ratio of 1.2%. The donor was a 72-yr old female
with 15-yr history of diabetes, which was relatively well controlled
(HbA1c=6.7%). Second, the composition of beta- (green), alpha-
(red), and delta- (blue) cells in islets was approximately 6:3:1
(Fig. 6B-D). In detail, however, the cellular composition depended
on islet size. The proportion of alpha-cells increased with islet size,
while the proportion of beta-cells reciprocally decreased with islet
size. This finding is consistent with previous reports [16–18]. Thus
Figure 3. Morphology of randomly selected islets. ND4, ND7, ND10, ND12: specimen from non-diabetic subjects. D4, D8-D10: specimens from
subjects with T2D. All listed by the ascending order of age in each group.
doi:10.1371/journal.pone.0027445.g003
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other hand, the proportion of delta-cells was independent from islet
size. In addition to the general features of cellular compositions in
islets, we found significant changes in the cellular compositions
in T2D. In large islets (.60 mm), beta-cell fraction decreased,
while alpha-cell fraction reciprocally increased, suggesting a
preferential loss of beta-cells. Delta-cell fraction did not change
in the large islets.
Islet architectures
To quantify cellular arrangement in islets, we calculated the
probabilities of contact between cell types as schematically
described in Fig. 7A. These can be a relevant measure of islet
architectures in the context of paracrine interactions between
neighboring cells. For example, we compared a random islet
structure with a regular islet structure with the same cellular
composition (Fig. 7B). The probabilities of contact between cell
Figure 4. Endocrine cell mass and characteristics of islet architecture. A: Inter-subject comparison. Total islet cell composition (beta-cells in
green, alpha-cells in red, and delta-cells in blue) in individual non-diabetic subjects (a) and T2D patients (b). B: Morphological changes observed in
large islets. Representative islets are pseudo-colored models of actual islets based on immunohistochemical images composed of beta-cells (green),
alpha-cells (red), and delta-cells (white). From left to right: compacted endocrine cell arrangement, relatively sparse architecture, the presence of a
population of cells lacking cytosolic hormones (blue), and cyst formation containing necrotic materials (purple). Corresponding small islets from the
same sections in a to d are shown in e to h.
doi:10.1371/journal.pone.0027445.g004
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First, we compared the real architecture of individual islets in
non-diabetic subjects with a random cell mixture while keeping
the same cellular composition. Note that we can theoretically
estimate the probabilities of contact between cell types in the
random cell mixture, given numbers of each cell type (see
Materials and Methods). The human islets showed more frequent
beta-beta cell contacts, but less frequent alpha-beta cell contacts,
compared with the random cell mixture (Fig. 7C). This
demonstrated that human islets were not a random mixture
of endocrine cells but had a characteristic structure. Second, we
compared the islet architectures between non-diabetic and T2D
subjects (Fig. 7D). In general, larger islets have more alpha-alpha
and alpha-beta cell contacts and less beta-beta cell contacts than
smaller islets, reflecting that alpha-cells are more abundant in
larger islets. In T2D, the preferential loss of beta-cells in the large
islets (.60 mm in diameter) resulted in relative increase of alpha-
cell fraction and decrease of beta-cell fraction. This altered cellular
composition lead to increased contacts between alpha-cells and
decreased contacts between beta-cells. Furthermore, the proba-
bility of contact between alpha- and beta-cells decreased in T2D,
because decreased beta-cell fraction was slightly dominant in the
Figure 5. Individual islet size distribution and cellular compositions. A: In non-diabetic subjects (ND1–ND14), relative frequency of islet size
(gray bar) and ratios of alpha (red), beta (green), and delta (blue) cells within islets were plotted against islet size; means 6 SEM. B: Results in T2D
patients (D1–D12). Note that islet size is presented as a logarithmic scale considering the high number of small islets and the low number of large
islets. In addition, we divided islet areas by the single-cell area, 170 mm
2 [29], to make them as dimensionless values representing the number of cells
in a given islet area. The conversion between logarithmic islet area (logarithmic) and effective diameter (mm) is shown.
doi:10.1371/journal.pone.0027445.g005
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delta-delta, delta-beta, and delta-alpha cell contacts also had
different patterns from the random cell mixture (Fig. 8A). T2D
subjects showed increased delta-delta, decreased delta-beta, and
increased delta-alpha cell contacts, compared with non-diabetic
subjects (Fig. 8B), which was consistent with decreased beta-cell
fraction and increased alpha-cell fraction in large islets. These
quantifications explicitly showed that the altered cellular compo-
sitions in T2D lead to the changes in cellular arrangement in large
islets.
Discussion
The etiology of T2D implicates peripheral resistance to insulin-
mediated glucose uptake that results in an increased demand for
insulin to control circulating glucose. The stress of meeting this
demand for insulin is followed by gradual loss of proper beta-cell
function and sufficient beta-cell mass [4,5,19,20,21]. When the
demand for insulin exceeds the compensatory mechanisms of the
body, it leads to chronic hyperglycemia, which is defined as
diabetes mellitus. Currently, there are no means available for
quantifying beta-cell mass in vivo in humans. Studies of the
endocrine pancreas in T2D have largely relied on autopsies.
Furthermore, clinical information is often limited and variable.
Particularly in the case of patients with T2D, determining the
precise onset of the disease is unrealistic due to the nature of its
gradual progression. Finally, precise comparative studies are
hampered by the difficulty of determining a control group in
human populations. In the present study, we aimed to evaluate the
pathophysiology of T2D within the limitations of the paucity of
autopsy specimens and clinical information.
We have developed a large-scale image analysis that can semi-
automatically quantify islet morphology and architecture in the
whole pancreatic section. The method provides representative islet
size distribution. Furthermore, high quality image capturing with
computer-aided focusing over hundreds of optical panels that
cover a whole section (which are subsequently merged into a single
montage) allows us to quantitatively analyze cellular composition
of each and every islet. In subjects with T2D, total beta-cell area
was significantly reduced as consistent with previous reports [21–
26]. In the present study, we found a preferential loss of large islets
(diameter .60 mm) and altered endocrine cell composition with a
reciprocal change of a decrease in beta-cell fraction and an
increase of alpha-cell fraction. However, total alpha-cell area was
decreased along with that of beta-cells. This is contrary to several
previous studies that reported alpha-cell expansion in T2D
patients [21,22,24], which may be due to sampling bias by
selecting specific regions with large islets. A recent study by
Henquin and Rahier on the other hand found that alpha-cell mass
was identical between T2D patients and non-diabetic subjects
[18]. This difference may be due to the method used in their study
(100–300 islets/section by point counting at X400 magnification),
whereas we quantify an average of .700 islets/section by
computer-assisted automated measurement. The important impli-
cation from these studies is that the relative hyperglucagonemia
often reported in T2D patients is not due to alpha-cell expansion.
Our automatic quantification of about 20,000 individual islets
clearly showed that human islets were not a random mixture of
Figure 6. Changes of islet size and cellular compositions in T2D. A: Mean relative frequencies of islet sizes and cellular compositions (B:
alpha-cell fraction, C: beta-cell fraction, and D: delta-cell fraction) depending on islet size in non-diabetic (gray; 8903 islets with n=14) and T2D
(color; 7929 islets with n=12) subjects (mean 6 SEM). The numbers in parentheses represent effective islet diameters (mm) corresponding to the
given logarithmic dimensionless islet areas. Student’s t-test compared the results between non-diabetic and T2D subjects at each size bin with
*P,0.05, **P,0.001, and ***P,0.0001.
doi:10.1371/journal.pone.0027445.g006
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other as in rodent islets. This is relevant to islet physiology that the
coupling between beta-cells is necessary to generate robust
electrical activity for efficient insulin secretion [27,28]. Thus, the
reduced beta-beta cell contacts observed in T2D may reduce
essential couplings between beta-cells resulting in inefficient insulin
secretion. Our analysis has also shown that higher alpha-cell ratios
are only observed in large islets and alpha-cell ratio increases with
islet size, which is consistent with previous studies by us [8–10] and
others [17,18]. In addition to the higher alpha-cell ratio, the
probability of contact between alpha- and beta-cells indeed
increased with islet size, suggesting that the interaction between
alpha- and beta-cells may play an important role in larger islets.
We propose that the analysis on beta-cell mass should be
conducted in the context of isle size distribution. When adjacent
tissue sections are available, the automated analysis can also be
applied to examine islet amyloid polypeptide (IAPP) deposits,
inflammation, necrosis, and replication with specific markers.
The large-scale analysis of human pancreas tissues described in
the present study can immediately be adopted for the post-
Figure 7. Changes of islet architecture in T2D. A: A simple example to calculate cellular compositions and probabilities of contact between cell
types in an islet consisting of 3 alpha- (red) and 4 beta- (green) cells. Lines represent contacts between neighboring cells. B: two examples of
distinctive architectures: random mixture of cells (left) and a regular structure (right) where cellular composition is the same (alpha:beta=3:7). The
numbers in parentheses are the probabilities of contact between cell types in the random cell mixture, which are theoretically estimated as (Paa =Pa
6Pa, Pbb =Pb 6Pb, Pab =Pa 6Pb +Pb 6Pa). C: Probabilities of alpha-alpha, beta-beta, and alpha-beta cell contacts in non-diabetic subjects (blue;
6886 islets with n=14). Those were compared with the theoretical estimation for random mixtures of cells (gray) where cellular compositions were
the same with the individual islets in non-diabetic subjects (mean 6 SEM). D: Comparison between non-diabetic (blue) and T2D (red; 5359 islets with
n=12) subjects. Note that scattered single endocrine cells are excluded in the calculation because contacting cells does not exist for them. The
numbers in parentheses represent effective islet diameters (mm) corresponding to the given logarithmic dimensionless islet areas. Student’s t-test
compared the results between non-diabetic and T2D subjects at each size bin with *P,0.05, **P,0.001, and ***P,0.0001.
doi:10.1371/journal.pone.0027445.g007
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PLoS ONE | www.plosone.org 9 November 2011 | Volume 6 | Issue 11 | e27445evaluation of the clinical outcomes of islet transplantation by
reserving a piece of pancreas tissue at the time of procurement, an
on-going project that we have initiated at the Pancreatic Islet
Isolation Laboratory at the University of Chicago. A possible
cohort study at multiple medical centers including re-evaluation of
existing samples in the field may help establish a universal scoring
method to evaluate islet quality for transplantation, and further
define the progression of diabetes that should lead to a better
understanding of the pathophysiology of the disease.
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